UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060808
Receipt number R000069409
Scientific Title Internet Survey on Colonoscopy Preparation - PRESS survey
Date of disclosure of the study information 2026/03/03
Last modified on 2026/03/03 12:52:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Internet Survey on Colonoscopy Preparation - PRESS survey

Acronym

Internet Survey on Colonoscopy Preparation - PRESS survey

Scientific Title

Internet Survey on Colonoscopy Preparation - PRESS survey

Scientific Title:Acronym

Internet Survey on Colonoscopy Preparation - PRESS survey

Region

Japan


Condition

Condition

Colonic disease

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A web-based questionnaire survey on pre-colonoscopy preparation procedures was conducted among physicians performing colonoscopies, primarily gastroenterologists, to clarify the current situation.

Basic objectives2

Others

Basic objectives -Others

About Colonoscopy Preparation

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Age, gender, affiliated medical institution, academic society membership, number of endoscopic examinations performed, use of bowel preparation agents, use of laxatives, location of bowel preparation agent administration, use of sedatives, rate of inadequate bowel preparation, key considerations for bowel preparation agents, confirmation of renal function and proportion of patients with impaired renal function, confirmation of constipation and proportion of constipation cases along with its impact, proportion of patients aged 65 years and older and 75 years and older

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Colonoscopy physicians registered in the Cross Marketing Co., Ltd. research cooperation panel who agreed to participate in this survey

Key exclusion criteria

None

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Minami
Middle name
Last name Umeyama

Organization

EA Pharma Co., Ltd.

Division name

Medical Science Group, Medical Dept.

Zip code

104-0042

Address

Sumitomo Irifune Bldg, 2-1-1, Irifune, Chuo-ku, Tokyo 104-0042, Japan

TEL

080-1016-4790

Email

minami_umeyama@eapharma.co.jp


Public contact

Name of contact person

1st name Minami
Middle name
Last name Umeyama

Organization

EA Pharma Co., Ltd.

Division name

Medical Science Group, Medical Dept.

Zip code

104-0042

Address

Sumitomo Irifune Bldg, 2-1-1, Irifune, Chuo-ku, Tokyo 104-0042, Japan

TEL

080-1016-4790

Homepage URL


Email

minami_umeyama@eapharma.co.jp


Sponsor or person

Institute

EA Pharma Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

EA Pharma Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yamauchi Clinic Research Ethics Committee

Address

1-15-9 Jiyugaoka, Meguro-ku, Tokyo

Tel

03-6777-1490

Email

c-irb_ug@neues.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 19 Day

Date of IRB

2026 Year 02 Month 19 Day

Anticipated trial start date

2026 Year 03 Month 09 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2026 Year 03 Month 03 Day

Last modified on

2026 Year 03 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069409